Once Weekly Infant Corticosteroid Trial for DMD
Condition:   Duchenne Muscular Dystrophy Intervention:   Drug: Prednisolone Sponsors:   Anne M. Connolly;   Ann& Robert H Lurie Children's Hospital of Chicago;   Children's Hospital Medical Center, Cincinnati Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2022 Category: Research Source Type: clinical trials

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)
Condition:   Lymphoma, Large B-Cell, Diffuse Interventions:   Biological: Zilovertamab Vedotin;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Biological: Rituximab;   Biological: Rituximab Biosimilar;   Drug: Prednisone;   Drug: Prednisolone Sponsor:   Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2022 Category: Research Source Type: clinical trials